annual cash & cash equivalents:
$167.00M-$35.00M(-17.33%)Summary
- As of today (August 18, 2025), CLX annual cash & cash equivalents is $167.00 million, with the most recent change of -$35.00 million (-17.33%) on June 30, 2025.
- During the last 3 years, CLX annual cash & cash equivalents has fallen by -$16.00 million (-8.74%).
- CLX annual cash & cash equivalents is now -80.83% below its all-time high of $871.00 million, reached on June 30, 2020.
Performance
CLX Cash and cash equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly cash & cash equivalents:
$167.00M-$59.00M(-26.11%)Summary
- As of today (August 18, 2025), CLX quarterly cash & cash equivalents is $167.00 million, with the most recent change of -$59.00 million (-26.11%) on June 30, 2025.
- Over the past year, CLX quarterly cash & cash equivalents has dropped by -$35.00 million (-17.33%).
- CLX quarterly cash & cash equivalents is now -85.78% below its all-time high of $1.17 billion, reached on March 31, 2018.
Performance
CLX quarterly cash & cash equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Cash and cash equivalents Formula
Cash & Cash Equivalents = Cash + Short-Term Investments
CLX Cash and cash equivalents Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -17.3% | -17.3% |
| 3 y3 years | -8.7% | -8.7% |
| 5 y5 years | -80.8% | -80.8% |
CLX Cash and cash equivalents Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -54.5% | at low | -67.8% | at low |
| 5 y | 5-year | -80.8% | at low | -80.8% | at low |
| alltime | all time | -80.8% | +154.8% | -85.8% | +256.1% |
CLX Cash and cash equivalents History
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2025 | $167.00M(-17.3%) | $167.00M(-26.1%) |
| Mar 2025 | - | $226.00M(-22.1%) |
| Dec 2024 | - | $290.00M(+4.3%) |
| Sep 2024 | - | $278.00M(+37.6%) |
| Jun 2024 | $202.00M(-45.0%) | $202.00M(-7.8%) |
| Mar 2024 | - | $219.00M(-38.3%) |
| Dec 2023 | - | $355.00M(-31.5%) |
| Sep 2023 | - | $518.00M(+41.1%) |
| Jun 2023 | $367.00M(+100.5%) | $367.00M(+51.7%) |
| Mar 2023 | - | $242.00M(+44.0%) |
| Dec 2022 | - | $168.00M(-39.6%) |
| Sep 2022 | - | $278.00M(+51.9%) |
| Jun 2022 | $183.00M(-42.6%) | $183.00M(-24.1%) |
| Mar 2022 | - | $241.00M(+25.5%) |
| Dec 2021 | - | $192.00M(-8.6%) |
| Sep 2021 | - | $210.00M(-34.2%) |
| Jun 2021 | $319.00M(-63.4%) | $319.00M(-35.2%) |
| Mar 2021 | - | $492.00M(-32.8%) |
| Dec 2020 | - | $732.00M(-14.9%) |
| Sep 2020 | - | $860.00M(-1.3%) |
| Jun 2020 | $871.00M(+684.7%) | $871.00M(+75.6%) |
| Mar 2020 | - | $496.00M(+195.2%) |
| Dec 2019 | - | $168.00M(+12.0%) |
| Sep 2019 | - | $150.00M(+35.1%) |
| Jun 2019 | $111.00M(-15.3%) | $111.00M(-37.6%) |
| Mar 2019 | - | $178.00M(+7.9%) |
| Dec 2018 | - | $165.00M(+1.9%) |
| Sep 2018 | - | $162.00M(+23.7%) |
| Jun 2018 | $131.00M(-68.9%) | $131.00M(-88.8%) |
| Mar 2018 | - | $1.17B(+140.1%) |
| Dec 2017 | - | $489.00M(+4.5%) |
| Sep 2017 | - | $468.00M(+11.2%) |
| Jun 2017 | $421.00M(+4.5%) | $421.00M(-2.3%) |
| Mar 2017 | - | $431.00M(+4.1%) |
| Dec 2016 | - | $414.00M(+1.5%) |
| Sep 2016 | - | $408.00M(+1.2%) |
| Jun 2016 | $403.00M(+4.4%) | $403.00M(-2.7%) |
| Mar 2016 | - | $414.00M(+6.2%) |
| Dec 2015 | - | $390.00M(+1.8%) |
| Sep 2015 | - | $383.00M(-0.8%) |
| Jun 2015 | $386.00M(+13.9%) | $386.00M(+2.1%) |
| Mar 2015 | - | $378.00M(-53.8%) |
| Dec 2014 | - | $819.00M(+130.7%) |
| Sep 2014 | - | $355.00M(+5.0%) |
| Jun 2014 | $339.00M(+8.7%) | $338.00M(-7.1%) |
| Mar 2014 | - | $364.00M(+6.7%) |
| Dec 2013 | - | $341.00M(+5.6%) |
| Sep 2013 | - | $323.00M(+3.5%) |
| Jun 2013 | $312.00M(+16.9%) | $312.00M(-26.2%) |
| Mar 2013 | - | $423.00M(-4.9%) |
| Dec 2012 | - | $445.00M(-33.3%) |
| Sep 2012 | - | $667.00M(+149.8%) |
| Jun 2012 | $267.00M(+3.1%) | $267.00M(-11.9%) |
| Mar 2012 | - | $303.00M(+2.0%) |
| Dec 2011 | - | $297.00M(+10.0%) |
| Sep 2011 | - | $270.00M(+4.2%) |
| Jun 2011 | $259.00M(+197.7%) | $259.00M(+69.3%) |
| Mar 2011 | - | $153.00M(-59.6%) |
| Dec 2010 | - | $379.00M(+32.5%) |
| Sep 2010 | - | $286.00M(+228.7%) |
| Jun 2010 | $87.00M(-57.8%) | $87.00M(-63.9%) |
| Mar 2010 | - | $241.00M(+56.5%) |
| Dec 2009 | - | $154.00M(-35.0%) |
| Sep 2009 | - | $237.00M(+15.0%) |
| Jun 2009 | $206.00M | $206.00M(+76.1%) |
| Mar 2009 | - | $117.00M(+20.6%) |
| Dec 2008 | - | $97.00M(-47.3%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2008 | - | $184.00M(-14.0%) |
| Jun 2008 | $214.00M(+17.6%) | $214.00M(-24.1%) |
| Mar 2008 | - | $282.00M(+0.7%) |
| Dec 2007 | - | $280.00M(+34.0%) |
| Sep 2007 | - | $209.00M(+14.8%) |
| Jun 2007 | $182.00M(-5.2%) | $182.00M(+6.4%) |
| Mar 2007 | - | $171.00M(-4.5%) |
| Dec 2006 | - | $179.00M(+2.9%) |
| Sep 2006 | - | $174.00M(-9.4%) |
| Jun 2006 | $192.00M(-34.5%) | $192.00M(-33.6%) |
| Mar 2006 | - | $289.00M(+5.9%) |
| Dec 2005 | - | $273.00M(0.0%) |
| Sep 2005 | - | $273.00M(-6.8%) |
| Jun 2005 | $293.00M(+26.3%) | $293.00M(0.0%) |
| Mar 2005 | - | $293.00M(-2.3%) |
| Dec 2004 | - | $300.00M(+17.6%) |
| Sep 2004 | - | $255.00M(+149.4%) |
| Jun 2004 | $232.00M(+31.1%) | - |
| Jun 2002 | $177.00M(-27.8%) | - |
| Jun 2000 | $245.00M(+85.6%) | - |
| Jun 1999 | $132.00M(+47.2%) | - |
| Dec 1998 | - | $102.24M(-6.3%) |
| Sep 1998 | - | $109.16M(+7.0%) |
| Jun 1998 | $89.68M(+26.0%) | $102.00M(+35.1%) |
| Mar 1998 | - | $75.50M(+48.3%) |
| Dec 1997 | - | $50.90M(-41.8%) |
| Sep 1997 | - | $87.40M(-13.5%) |
| Jun 1997 | - | $101.00M(-11.2%) |
| Mar 1997 | - | $113.70M(+40.5%) |
| Dec 1996 | - | $80.90M(-30.7%) |
| Sep 1996 | - | $116.80M(+28.6%) |
| Jun 1996 | - | $90.80M(+2.7%) |
| Mar 1996 | - | $88.40M(-16.5%) |
| Dec 1995 | - | $105.90M(-17.1%) |
| Sep 1995 | - | $127.80M(-6.9%) |
| Jun 1995 | - | $137.30M(+47.8%) |
| Mar 1995 | - | $92.90M(-30.9%) |
| Dec 1994 | - | $134.40M(-11.5%) |
| Sep 1994 | - | $151.90M(+31.1%) |
| Jun 1994 | - | $115.90M(+1.4%) |
| Mar 1994 | - | $114.30M(-15.5%) |
| Dec 1993 | - | $135.30M(-31.6%) |
| Sep 1993 | - | $197.90M(+177.9%) |
| Jun 1993 | $71.16M(-72.6%) | $71.20M(+51.8%) |
| Mar 1993 | - | $46.90M(-20.9%) |
| Dec 1992 | - | $59.30M(-9.2%) |
| Sep 1992 | - | $65.30M(-5.4%) |
| Jun 1992 | - | $69.00M(-15.3%) |
| Mar 1992 | - | $81.50M(+29.8%) |
| Dec 1991 | - | $62.80M(-7.5%) |
| Sep 1991 | - | $67.90M(-40.4%) |
| Jun 1991 | - | $113.90M(+115.3%) |
| Mar 1991 | - | $52.90M(+1.7%) |
| Dec 1990 | - | $52.00M(-21.1%) |
| Sep 1990 | - | $65.90M(-47.1%) |
| Jun 1990 | - | $124.60M(+21.4%) |
| Mar 1990 | - | $102.60M(-52.2%) |
| Dec 1989 | - | $214.80M(-14.4%) |
| Sep 1989 | - | $251.00M(+7.6%) |
| Jun 1989 | - | $233.30M(-10.0%) |
| Jun 1988 | $259.28M(+26.3%) | $259.30M(+5.6%) |
| Jun 1987 | - | $245.50M(+19.6%) |
| Jun 1986 | $205.32M(+88.8%) | $205.30M(+15.3%) |
| Jun 1985 | - | $178.00M(+51.9%) |
| Jun 1984 | - | $117.20M |
| Jun 1983 | $108.76M(+65.9%) | - |
| Jun 1982 | $65.56M | - |
FAQ
- What is The Clorox Company annual cash & cash equivalents?
- What is the all time high annual cash & cash equivalents for The Clorox Company?
- What is The Clorox Company annual cash & cash equivalents year-on-year change?
- What is The Clorox Company quarterly cash & cash equivalents?
- What is the all time high quarterly cash & cash equivalents for The Clorox Company?
- What is The Clorox Company quarterly cash & cash equivalents year-on-year change?
What is The Clorox Company annual cash & cash equivalents?
The current annual cash & cash equivalents of CLX is $167.00M
What is the all time high annual cash & cash equivalents for The Clorox Company?
The Clorox Company all-time high annual cash & cash equivalents is $871.00M
What is The Clorox Company annual cash & cash equivalents year-on-year change?
Over the past year, CLX annual cash & cash equivalents has changed by -$35.00M (-17.33%)
What is The Clorox Company quarterly cash & cash equivalents?
The current quarterly cash & cash equivalents of CLX is $167.00M
What is the all time high quarterly cash & cash equivalents for The Clorox Company?
The Clorox Company all-time high quarterly cash & cash equivalents is $1.17B
What is The Clorox Company quarterly cash & cash equivalents year-on-year change?
Over the past year, CLX quarterly cash & cash equivalents has changed by -$35.00M (-17.33%)